Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-3758309 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
PF-3758309 is a p21-activated kinase (PAK) inhibitor with activity against PAK1 and PAK4, potentially resulting in decreased tumor growth (PMID: 20439741, PMID: 23543898, PMID: 32469945, PMID: 31312349). |
| DrugClasses | PAK1 Inhibitor 11 |
| CAS Registry Number | 898044-15-0 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JQ1 + PF-3758309 | JQ1 PF-3758309 | 0 | 0 |
| PF-3758309 | PF-3758309 | 0 | 0 |